196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer. (13th May 2019)

Record Type:
Journal Article
Title:
196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer. (13th May 2019)
Main Title:
196TiPSGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer
Authors:
Boni, V
Alemany, C
Meisel, J L
Sinha, R
Sterrenberg, D
Tkaczuk, K H R
Wang, Y
Wang, Z
Han, H S
Abstract:
Is Part Of:
Annals of oncology. Volume 30(2019)Supplement 3
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 3
Issue Display:
Volume 30, Issue 3 (2019)
Year:
2019
Volume:
30
Issue:
3
Issue Sort Value:
2019-0030-0003-0000
Page Start:
Page End:
Publication Date:
2019-05-13
Subjects:
Oncology -- Periodicals
616.992
Journal URLs:
https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:
10.1093/annonc/mdz100.047 ↗
Languages:
English
ISSNs:
0923-7534
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
11798.xml